Article
Molecular benchmarks of a SARS-CoV-2 epidemic.
Nature communications - 15 Jun 2021
Jonsson Hakon, Magnusson Olafur T, Melsted Pall, Berglund Jonas, Agustsdottir Arna B, Eiríksdottir Berglind, Fridriksdottir Run, Garðarsdottir Elisabet Eir, Georgsson Gudmundur, Gretarsdottir Olafia S, Guðmundsson Kjartan R, Gunnarsdottir Thora Rosa, Eggertsson Hannes, Gylfason Arnaldur, Holm Hilma, Jensson Brynjar O, Jonasdottir Aslaug, Jonsson Frosti, Josefsdottir Kamilla S, Thordardottir Marianna, Kristinsson Karl G, Kristjánsson Þórður, Magnusdottir Droplaug N, Roux Louise le, Saemundsdottir Jona, Sigurdsson Asgeir, Sigmundsdottir Gudrun, Sveinbjornsson Gardar, Rognvaldsson Solvi, Eiriksson Ogmundur, Magnusson Magnus Karl, Sveinsdottir Kristin Eva, Sveinsdottir Maney, Thorarensen Emil Aron, Thorbjornsson Bjarni, Löve Arthur, Norddahl Gudmundur L, Jonsdottir Ingileif, Sulem Patrick, Masson Gisli, Moller Alma, Gudnason Thorolfur, Kristjansson Mar, Helgason Agnar, Gudbjartsson Daniel F, Thorsteinsdottir Unnur, Stefansson Kari
Abstract excerpt
A pressing concern in the SARS-CoV-2 epidemic and other viral outbreaks, is the extent to which the containment measures are halting the viral spread. A straightforward way to assess this is to tally the active cases and the recovered ones throughout the epidemic. Here, we show how epidemic control can be assessed with molecular information during a well characterized epidemic in Iceland. We demonstrate how the...
Read the complete abstract on PubMed